Eli Lilly and Company (LLY.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
At close: 09:05AM CEST
| Previous close | 675.00 |
| Open | 675.00 |
| Bid | 695.00 x 0 |
| Ask | 785.00 x 0 |
| Day's range | 675.00 - 675.00 |
| 52-week range | 386.00 - 740.00 |
| Volume | |
| Avg. volume | 1,638 |
| Market cap | 654.39B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 109.93 |
| EPS (TTM) | 6.14 |
| Earnings date | 08 Aug 2024 |
| Forward dividend & yield | 4.71 (0.70%) |
| Ex-dividend date | 15 May 2024 |
| 1y target est | N/A |
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
Investor's Business DailyHow A Top Fund Beats The Market By Owning Future Leaders
Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities, isn't interested in blue-chip stars of yesteryear.
ZacksZacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
Eaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
© 2024 Yahoo. All rights reserved.